Why Life Science Manufacturers

A shift in thinking is underway

For years, a common assumption shaped how biopharma and medical device companies built their technology stacks: Microsoft Dynamics 365 was a general-purpose ERP, and GxPregulated manufacturing required something different sitting alongside it. A specialised EQMS. A patchwork of third-party compliance tools. A set of spreadsheets to bridge the gaps.

That thinking is evolving, and the change is opening up real possibilities for life science organisations willing to look at the platform with fresh eyes.

In a recent conversation, Matt Birtwistle, Manufacturing Industry Lead at Nexer, and Bill Burke, CEO of Merit Solutions, a software company exclusively serving life science and regulated industry manufacturers with GxP-compliant ERP and quality management software built on Microsoft Dynamics 365, explored what is actually driving this shift and what it means for life science leaders evaluating their digital infrastructure today.

What organisations are discovering Matt Birtwistle has observed this pattern consistently across the sector. The moment a pharma business truly understands what D365 can do in a regulated environment, he notes, is often one of genuine surprise. Companies have built up a legacy of using dedicated third-party add-on solutions alongside their ERP, assuming that GxP compliance requires a separate system.

What they find, when they look more closely, is that a modern, flexible platform like Microsoft Dynamics 365 can actually accommodate those processes within the same environment. The relief of that discovery is something he sees regularly in organisations that have been carrying the overhead of disconnected systems for years.

The practical implications become clear quickly. A quality ops team no longer working across multiple logins, reconciling data between systems, or maintaining custom integrations is a team with more time and more confidence in the information in front of them.

What makes D365 different for regulated manufacturers

Bill Burke is precise about what Dynamics 365 is and is not out of the box. The base application does not meet GxP compliance requirements on its own, but it provides the structural foundation that Merit builds on to enable those workloads. What distinguishes it from other ERP alternatives, in his view, is its native relationship to the broader Microsoft technology stack.

Because D365 is built within an ecosystem that already includes AI and enterprise-grade security, regulated manufacturers do not need to write and maintain integrations to reach those capabilities. They are already present in the platform. That has meaningful implications for cost, headcount, and the complexity of a company’s long-term technology strategy. As Bill explained in their conversation, the industry is now at a point where every biopharma and medical device company will need to operate in a technology platform that genuinely leverages AI. The question is which path gets them there most efficiently, and whether the ERP they choose positions them to take advantage of that natively or requires ongoing integration work to get there.

The ecosystem advantage

Matt also highlighted something that does not always surface prominently in ERP evaluations: the Microsoft Trust Center and the compliance documentation it provides for supplier validation.  The materials needed for GAMP 5 Category 4 COTS compliance are consistently available, well-organised, and easy to access. For a CSV person working through a supplier validation, that kind of documentation infrastructure is a meaningful time saver and a signal that the platform understands what regulated customers actually need.

Bill extended that point to Microsoft’s cloud update cadence, twice per year, with a consistent and well-documented approach for regulated industry customers. A predictable update schedule that accounts for validation requirements helps GMP-regulated manufacturers stay current on the platform without triggering a full revalidation cycle every time a release lands.

What this means for your technology strategy

The conclusion for life science leaders is not simply that D365 can handle regulated workloads. It is that choosing D365, with Merit’s GxP layer and Nexer’s advisory expertise, is a decision to operate within a technology ecosystem where AI capability, enterprise security, compliance documentation, and a cloud architecture are already part of the foundation.

As Matt put it, the investment decision for a CIO is no longer just about the ERP system itself. You are buying into an ecosystem that encompasses the whole range of technologies on offer, from AI tools to data fabric capabilities to reporting infrastructure. The ERP is the starting point, not the full picture.

For companies in life sciences, that framing changes the conversation considerably.

For more information, please contact
Matt Birtwistle
Manufacturing Industry Lead
Matt.Birtwistle@nexergroup.com